Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy
Advanced Materials · 2024-05 · 36 (21)
DOI: 10.1002/adma.202313953 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 04.03.2024. Verfasst von Yaofeng Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Resources, School of Food Science and Technology, Nanchang University, Nanchang, 330047, P. R. China. Hauptthemen laut MEDLINE: Neoplasms, Nanomedicine. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 301 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Jiangxi Province, Double-Thousand Plan of Jiangxi Province.
Abstract (Originalsprache)
Engineered bacteria are widely used in cancer treatment because live facultative/obligate anaerobes can selectively proliferate at tumor sites and reach hypoxic regions, thereby causing nutritional competition, enhancing immune responses, and producing anticancer microbial agents in situ to suppress tumor growth. Despite the unique advantages of bacteria‐based cancer biotherapy, the insufficient treatment efficiency limits its application in the complete ablation of malignant tumors. The combination of nanomedicine and engineered bacteria has attracted increasing attention owing to their striking synergistic effects in cancer treatment. Engineered bacteria that function as natural vehicles can effectively deliver nanomedicines to tumor sites. Moreover, bacteria provide an opportunity to enhance nanomedicines by modulating the TME and producing substrates to support nanomedicine‐mediated anticancer reactions. Nanomedicine exhibits excellent optical, magnetic, acoustic, and catalytic properties, and plays an important role in promoting bacteria‐mediated biotherapies. The synergistic anticancer effects of engineered bacteria and nanomedicines in cancer therapy are comprehensively summarized in this review. Attention is paid not only to the fabrication of nanobiohybrid composites, but also to the interpromotion mechanism between engineered bacteria and nanomedicine in cancer therapy. Additionally, recent advances in engineered bacteria‐synergized multimodal cancer therapies are highlighted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Food Science and Resources, School of Food Science and Technology, Nanchang University, Nanchang, 330047, P. R. China.
- Department of Thoracic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, P. R. China.
- Department of Cardiology, Jiangxi Hypertension Research Institute, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, P. R. China.
- School of Engineering, Westlake University, Hangzhou, 310030, P. R. China.
- National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, 330036, P. R. China.
- Key Laboratory of Superlight Materials and Surface Technology Ministry of Education, College of Material Sciences and Chemical Engineering, Harbin Engineering University, Harbin, 150001, P. R. China.
ORCID-Profile: Ben Zhong Tang
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Jiangxi Province
- Double-Thousand Plan of Jiangxi Province
- Jiangxi Provincial Natural Science Foundation
- First Affiliated Hospital of Nanchang University
- Innovation Fund Designated for Graduate Students of Jiangxi Province
- State Key Shenzhen Key Laboratory of Functional Aggregate Materials
- Science, Technology and Innovation Commission of Shenzhen Municipality
Zitieren
APA
Zhou, Y., Li, Q., Wu, Y., Zhang, W., Ding, L., Ji, C., Li, P., Chen, T., Feng, L., Tang, B. Z., & Huang, X. (2024). Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy. Advanced Materials, 36(21). https://doi.org/10.1002/adma.202313953
Vancouver
Zhou Y, Li Q, Wu Y, Zhang W, Ding L, Ji C, et al. Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy. Advanced Materials. 2024;36(21). doi:10.1002/adma.202313953
BibTeX
@article{Zhou2024,
author = {Zhou, Yaofeng and Li, Qianying and Wu, Yuhao and Zhang, Wan and Ding, Lu and Ji, Chenlin and Li, Ping and Chen, Tingtao and Feng, Lili and Tang, Ben Zhong and Huang, Xiaolin},
title = {Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {21},
doi = {10.1002/adma.202313953}
}
EUVIMED